Global Director Biosimilar Pipeline Strategy

Sandoz International GmbH; Madrid; Presencial; EUR 180.000 - 240.000; Jornada completa

Descripción de la vacante

Sandoz International GmbH is seeking a Global Director Pipeline Biosimilar Platform to shape the future of our global biosimilar pipeline. You will sit at the crossroads of science, commercial strategy, and investment decisions—helping determine which biosimilar assets to invest in, when, and at what scale.

You’ll work with commercial, R&D, regulatory, market access, manufacturing, and competitive intelligence teams to ensure portfolio choices are scientifically sound, commercially attractive,

Formación

• Minimum 12 years pharma industry expertise.
• Strong specialty care and biologics background (oncology, immunology, rare diseases).
• Ability to integrate scientific assessments, market trends, competitive threats, and evolving policy landscapes into clear strategic recommendations.
• Experience leading cross functional teams and influencing senior decision making. Direct people leadership experience is strongly preferred.

Responsabilidades

• Shaping global biosimilar pipeline strategy, including molecule/platform selection and portfolio balancing.
• Building differentiated perspectives (thought‑leadership) on emerging technologies, disease trends, and global market evolution.
• Driving rigorous forecasting, valuation, and scenario planning—incorporating development risk, commercial uncertainty, IP dynamics, and competitive threat modelling.

Conocimientos

Strategic thinking

Portfolio management

Forecasting

Stakeholder engagement

Fluent English

Educación

MD or PhD or MBA or equivalent

Descripción del empleo

Sandoz International GmbH is seeking a Global Director Pipeline Biosimilar Platform to shape the future of our global biosimilar pipeline. You will sit at the crossroads of science, commercial strategy, and investment decisions—helping determine which biosimilar assets to invest in, when, and at what scale.

You’ll work with commercial, R&D, regulatory, market access, manufacturing, and competitive intelligence teams to ensure portfolio choices are scientifically sound, commercially attractive,